Most recently, it's been recognized that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in similar spots as classical opioid receptors, it binds to the wide array of endogenous opioids. In contrast to most opioid receptors, this receptor functions like a scavenger and does not activate a 2nd